ERYP.PA - ERYTECH Pharma S.A.

Paris - Paris Delayed Price. Currency in EUR
Currency in EUR

Valuation Measures

Market Cap (intraday) 5120.9M
Enterprise Value 3-15.4M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)30.22
Price/Book (mrq)0.83
Enterprise Value/Revenue 3-3.85
Enterprise Value/EBITDA 60.33

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,190.60%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)4M
Revenue Per Share (ttm)0.22
Quarterly Revenue Growth (yoy)-37.10%
Gross Profit (ttm)4.45M
EBITDA -46.8M
Net Income Avi to Common (ttm)-38.14M
Diluted EPS (ttm)-2.13
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)134.37M
Total Cash Per Share (mrq)7.49
Total Debt (mrq)2.02M
Total Debt/Equity (mrq)1.39
Current Ratio (mrq)N/A
Book Value Per Share (mrq)8.12

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A

Trading Information

Stock Price History

Beta (3Y Monthly) 2.13
52-Week Change 3-61.60%
S&P500 52-Week Change 34.63%
52 Week High 317.13
52 Week Low 35.61
50-Day Moving Average 37.07
200-Day Moving Average 37.04

Share Statistics

Avg Vol (3 month) 334.66k
Avg Vol (10 day) 334.44k
Shares Outstanding 517.94M
Float 10.23M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A